ADIPOQ and metabolic syndrome: Multivariate analysis for kidney transplant recipient patients showed that the presence of metabolic syndrome early after transplantation was independently associated with decreased plasma values of adiponectin (β: -6.39, r (2) 0.195, P<0.0001) and increased risk for clinical events (OR: 5.6, 95% CI: 1.9, 16.5; P<0.01) (22).